(Q39328851)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27696251%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

title

Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27696251%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27696251%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Lukas C Heukamp

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27696251%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Lydia Meder

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27696251%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Lars C Moeller

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27696251%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

author name string

Soeren Latteyer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27696251%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Vera Tiedje

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27696251%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Katharina König

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27696251%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Kurt Werner Schmid

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27696251%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Dagmar Führer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27696251%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

publication date

1 October 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27696251%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27696251%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27696251%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27696251%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

page(s)

733-741

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27696251%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12020-016-1080-9

24 March 2020

exact match

0 references

cites work

Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Molecular pathogenesis and mechanisms of thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Cell cycle deregulation and TP53 and RAS mutations are major events in poorly differentiated and undifferentiated thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Mutation of the PIK3CA gene in anaplastic thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Association of PTEN gene methylation with genetic alterations in the phosphatidylinositol 3-kinase/AKT signaling pathway in thyroid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

The Akt-specific inhibitor MK2206 selectively inhibits thyroid cancer cells harboring mutations that can activate the PI3K/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

BRAF V600E inhibition in anaplastic thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Response and acquired resistance to everolimus in anaplastic thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Highly prevalent TERT promoter mutations in aggressive thyroid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Quality control of next-generation sequencing data without a reference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Proteomics. Tissue-based map of the human proteome

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

21 January 2018

12 December 2020

Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase-Rearranged Anaplastic Thyroid Carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

BLAT—The BLAST-Like Alignment Tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Using BLAT to find sequence similarity in closely related genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Integrative genomics viewer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

BRAF mutations in papillary carcinomas of the thyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

BRAF mutations in an Italian cohort of thyroid cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Integrated genomic characterization of papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

The anaplastic lymphoma kinase in the pathogenesis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Anaplastic lymphoma kinase: signalling in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-1080-9

Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer

21 January 2018

1 reference

12 December 2020

Search for new genetic biomarkers in poorly differentiated and anaplastic thyroid carcinomas using next generation sequencing

1 reference

12 December 2020

Anaplastic thyroid cancer

1 reference

12 December 2020

Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis

1 reference

12 December 2020

10.1007/S12020-016-1080-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27696251%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

1 reference